Mater Specialist Quick Find

Gynaecology - public patient

Purpose

This page contains information for general practitioners on how to refer patients aged 16 years and over to Gynaecology services at Mater Hospital Brisbane.

Service 

The Gynaecology Service offers a comprehensive individualised approach to patient care. The multidisciplinary team consists of medical specialists, case managers and clinical nurses with access to allied health services including physiotherapy, psychology, social work, occupational therapy and dietetics. 

The Gynaecology service also offers specialised services for young adults aged 16 - 25 years at the Mater Young Adult Health Centre Brisbane. These clinics offers a number of clinical services and programs that have been developed with young people in mind.

Other specialised clinics include 

  • Colposcopy
  • Infertility 

How to Refer

If referral for care is indicated please list all of the General Referral Information, reason for request, and essential information as indicated below.

Referrals can be sent by:

Smart Referrals

Digital referrals in your practice software that include templates linked with referral criteria for quality handover for any public hospital

SmartForms

Cloud solution in your practice software that eliminates the need for template management

Secure messaging

Medical Objects:   HM4101000R8

HealthLink EDI: materref     

Fax         07 3163 8548

For fax and secure messaging our latest Mater Adult Referral Form or Antenatal Form are available to  embed into most major Practice Management software systems.  

Emergency

If any of the following are present or suspected, phone 000 to arrange immediate transfer to the emergency department or seek emergency medical advice if in a remote region:

 

View list of conditions:

  • Ectopic pregnancy
  • Ruptured haemorrhagic ovarian cyst
  • Torsion of uterine appendages
  • Acute/severe pelvic pain
  • Significant or uncontrolled vaginal bleeding
  • Severe infection
  • Abscess intra pelvis or PID
  • Bartholin’s abscess / acute painful enlargement of a Bartholin’s gland/cyst
  • Acute trauma including vulva/vaginal lacerations, haematoma and/or penetrating injuries
  • Post-operative complications within 6 weeks including wound infection, wound breakdown, vaginal bleeding/discharge, retained products of conception post-op, abdominal pain
  • Urinary retention
  • Acute Urinary obstruction
  • Unstable Molar pregnancy
  • Inevitable and / or incomplete abortion
  • Hyperemesis gravidarum
  • Ascites, secondary to known underlying gynaecological oncology

 

 

Scope of Service

Conditions out of scope

The following conditions are not routinely provided at Mater Hospital Brisbane:

View list of conditions:

  • Elective cosmetic surgery e.g. labiaplasty
  • Tubal ligation (including reversal of tubal ligation)
  • Contraception
    • Contraceptive Advice
    • Contraception e.g. Implanon
    • Routine Mirena®/ progesterone-releasing IUD insertion for contraception
    • Elective Termination of Pregnancy
  •  Screening Pap Smears
  • Primary menopausal care
  •  Screening pap smear
  • Postnatal check-up
  • IVF services

 

Conditions in scope

Abnormal cervical screening, Cervical Dysplasia, Abnormal Cervix

Essential information (Referral will be declined without this)

  • General referral information
  • History of
    • any abnormal bleeding (i.e. post-coital and  intermenstrual) or abnormal discharge
    • previous abnormal cervical screening
    • immunosuppressive therapy
  • Medical management to date
  • Most recent and current cervical screening (LBC should be performed on any sample with positive oncogenic HPV)

Additional referral information (useful for processing the referral)

  • HPV vaccination history
  • STI screen result endocervical swab or first catch urine for chlamydia +/- gonorrhoea NAA
  • History of smoking

Other useful information for management (not an exhaustive list)

  • Refer to Healthpathways or local guidelines
  • Women who are in follow-up for pLSIL / LSIL in cytology in the previous program (pre-renewal NCSP) should have a HPV test at their next scheduled follow-up appointment
    • If oncogenic HPV is not detected, the women can return to 5-yearly screening
    • If any HPV is detected, the woman should be referred for colposcopic assessment
  • A single cervical screening test may be considered for women between the ages of 20 and 24 years who experience their first sexual activity at a young age (e.g. before 14 years) who have not recieved the HPV vaccine before sexual activity commenced
  • Adolescent patients with abnormal HPV should follow the same pathway as adult patients. Patients <25 years old should also have screening for STI as they are a high-risk group.
  • Consider using oestrogen cream +/- liquid cytology in post-menopausal women
  • Patients with positive non-16/18 but normal or LSIL on LBC would not need referral and only a repeat CST in 12 months 
  • Recall women in 6-12 weeks if they have an unsatisfactory screening report
  • Specific efforts should be made to provide screening for Aboriginal and Torres Strait Islander women. They should be invited and encouraged to participate in the NCSP and have a 5-yearly HPV test, as recommended for all Australian women
  • Women who have been treated for HSIL (CIN2/3) do not need a post-treatment colposcopy. These women should have a co-test (HPV and LBC test) performed at 12 months after treatment, and annually thereafter, until she receives a negative co-test on two consecutive occasions, when she can return to routine 5 yearly screening. This is called ‘test of cure’.
  • If, at any time post treatment, the woman has a positive oncogenic HPV (16/18) test result, she should be referred for colposcopic assessment (regardless of the reflex LBC result).
  • If, at any time during Test of Cure, the woman has a LBC prediction of pHSIL/HSIL or any glandular abnormality, irrespective of HPV status, she should be referred for colposcopic assessment.
Clinical resources

Categorisation

Available appointments are provided to our patients based on clinical priority. A process of categorisation ensures safety and equity of access.

Category 1 – Urgent

Clinically recommended timeframe for initial appointment is 30 days

Category 2 - Priority

Clinically recommended timeframe for initial appointment is 90 days

Category 3 - Routine

Clinically recommended timeframe for initial appointment is 365 days

Invasive Cancer (SCC, glandular, other). For optimum care, patient should be seen by gynaecological oncology within 2 weeks. 

LBC of PHSIL / HSIL

AIS or possible high grade glandular lesion 

Positive HPV 16/18 and 

  • unsatisfactory LBC
  • previous treatment for PHSIL/HSIL
  • Past history of positive HPV 16/18 
  • Atypical glandular cells/endocervical cells of undetermined significance

Positive HPV non-16/18 and 

  • Atypical glandular cells/endocervical cells of undetermined significance

 

Positive HPV 16/18 and 

  • Normal LBC
  • PLSIL / LSIL 

Positive HPV non 16/18 and 

  • Previous test positive for oncogenic HPV
  • Women aged 70-74
  • Immune deficiency 

History of diethylstilboestrol (DES) exposure regardless of HPV status or LBC test 

Abnormal appearing cervix with normal cervical screening

Recurrent post-coital bleeding in pre-menopausal woman – gynaecological assessment recommended

Any episode of unexplained vaginal bleeding (including post-coital) in a post-menopausal woman

Unexplained persistent unusual vaginal discharge, especially if offensive and blood stained

Any abnormal result and past history of excisional treatment of AIS

No category 3 criteria

 

Cervical Polyp

Essential information (Referral will be declined without this)

Additional referral information (useful for processing the referral)

  • HRT use

Other useful information for management (not an exhaustive list)

  • Small endocervical polyps (<2cm) in premenopausal women with normal cervical screening can be avulsed and sent for histology
  • Cervical polyps in post-menopausal women have a higher risk of malignancy
  • Refer to Healthpathways or local guidelines

Categorisation

Available appointments are provided to our patients based on clinical priority. A process of categorisation ensures safety and equity of access.

Category 1 – Urgent

Clinically recommended timeframe for initial appointment is 30 days

Category 2 - Priority

Clinically recommended timeframe for initial appointment is 90 days

Category 3 - Routine

Clinically recommended timeframe for initial appointment is 365 days

SCC, positive oncogenic HPV and/or HSIL on LBC, glandular lesion on cervical screening

Cervical polyps in post-menopausal women with normal cervical screening

Cervical polyps in pre-menopausal women with normal cervical screening

 

Dyspareunia

Essential information (Referral will be declined without this)

  • General referral information
  • History of:
    • nature of the pain – location, intermittent or persistent
    • general body muscle tensing and general or focal pelvic floor muscle tension before and during attempts at penetration
    • medical, surgical and obstetric history
  • Pelvic USS results (TVS preferable)

Additional referral information (useful for processing the referral)

  • STI screen result – endocervical swab or first catch urine for chlamydia +/- gonorrhoea NAA
  • HVS M/C/S and viral PCR result
  • Previous CST result (if within last 5 years)

Other useful information for management (not an exhaustive list)

  • Advise using lubricant and adequate foreplay prior to intercourse
  • Refer to Healthpathways or local guidelines.
  • For superficial dyspareunia: (consider referral to women’s health physiotherapist)
    • breast feeding women – consider topical oestrogen
    • consider vaginismus and referral to a sexual medicine service
    • consider psychosocial issues and referral for counselling

Clinical resources

Categorisation

Available appointments are provided to our patients based on clinical priority. A process of categorisation ensures safety and equity of access.

Category 1 – Urgent

Clinically recommended timeframe for initial appointment is 30 days

Category 2 - Priority

Clinically recommended timeframe for initial appointment is 90 days

Category 3 - Routine

Clinically recommended timeframe for initial appointment is 365 days

No category 1 criteria

Severe pelvic pain associated with dyspareunia

Unexplained persistent unusual vaginal discharge, especially if offensive and blood stained

Vulvodynia/Vulvar vestibulitis syndrome

 

Fibroids

Essential information (Referral will be declined without this)

  • General referral information
  • History of:
    • symptoms
    • Heavy menstrual Bleeding (HMB), brief description of periods, medical management to date
    • dragging sensation
    • urinary frequency
  • Most recent or current cervical screening
  • FBC iron studies results
  • Pelvic USS (TVS preferable)

Additional referral information (useful for processing the referral)

  • No additional information

Other useful information for management (not an exhaustive list)

  • If asymptomatic (e.g normal menstrual pattern, normal Hb, post menopausal) there is no need for referral
  • Refer to Healthpathways or local guidelines

Categorisation

Available appointments are provided to our patients based on clinical priority. A process of categorisation ensures safety and equity of access.

Category 1 – Urgent

Clinically recommended timeframe for initial appointment is 30 days

Category 2 - Priority

Clinically recommended timeframe for initial appointment is 90 days

Category 3 - Routine

Clinically recommended timeframe for initial appointment is 365 days

Suspicion of degeneration or malignancy

Urinary obstruction, renal impairment e.g. hydroneprhosis, history of urinary retention

Heavy Menstrual Bleeding (HMB) with anaemia (Hb<85) or requiring transfusion

Fibroid prolapse through cervix

Pressure symptoms (such are ureteric impingement)

HMB with anaemia (Hb>85)

Abdominal discomfort

HMB without anaemia not responding to maximal medical management

Fibroids and reproductive issues

 

Heavy Menstrual Bleeding

Essential information (Referral will be declined without this)

  • General referral information
  • Brief description of periods
  • Medical management to date
  • Current cervical screening
  • FBC Serum ferritin results
  • Pelvic USS (TVS preferable)
  • Adolescent patient - Coag profile including von Willebrand's disease (vWD)

Additional referral information (useful for processing the referral)

  • TSH if symptomatic of thyroid disease
  • Previous management modalities, iron utilisation if deficient.

Other useful information for management (not an exhaustive list)

  • A woman with heavy menstrual bleeding is referred for early specialist review when there is a suspicion of malignancy or other significant pathology based on clinical assessment or ultrasound.  Link: https://www.safetyandquality.gov.au/our-work/clinical-care-standards/heavy-menstrual-bleeding/
  • Consider increased risk of hyperplasia or malignancy if:
    • Endometrial thickness greater than 12mm (transvaginal USS ideally day 4-7)
    • Irregular endometrium or focal lesion
    • Weight >90kg
    • PCOS / diabetes / unopposed oestrogen
    • Age >45yrs
    • Intermenstrual or post-coital bleeding

Medical treatment prior to or while waiting for specialist review if no suspicion of malignancy:

  • Progesterone releasing IUD
  • Tranexamic acid
  • OCP
  • NSAIDS
  • Oral progestogens

Referral is also arranged for a woman who has not responded after six months of medical treatment.

Categorisation

Available appointments are provided to our patients based on clinical priority. A process of categorisation ensures safety and equity of access.

Category 1 – Urgent

Clinically recommended timeframe for initial appointment is 30 days

Category 2 - Priority

Clinically recommended timeframe for initial appointment is 90 days

Category 3 - Routine

Clinically recommended timeframe for initial appointment is 365 days

Suspicion of malignancy

HMB with anaemia (Hb<85)

HMB with anaemia (Hb>85)

HMB without anaemia not responding to medical management

 

Infertility, RPL

Essential information (Referral will be declined without this)

  • General referral information
  • History of
    • previous pregnancies, STDs and PID, surgery, endometriosis
    • other medical conditions
  • Include the following information about partner
    • age and health, reproductive history, testicular conditions
  • Weight/ BMI
  • FBC Group and antibodies Rubella IgG Varicella IgG, Syphilis Serology, HBV/HCV/HIV serology results
  • Day 21 serum progesterone level (7 days before the next expected period)
  • FSH, LH (Day 2-5), Prolactin, TSH if cycle prolonged and/or irregular
  • STI screen result – endocervical swab or first catch urine for chlamydia +/- gonorrhoea NAA
  • Partner seminal analysis result
  • Pelvic USS (TVS preferable)
  • If  PCOS is suspected include the following:
    • SHBG results
    • Testosterone, DHEA-S results
    • Fasting blood glucose results
    • Lipids, TSH results
  • Include a referral with the following information for the partner
    • age and health, reproductive history, testicular conditions, seminal analysis result

Additional referral information (useful for processing the referral)

  • History of marijuana use (including partner)
  • Fasting blood glucose, testosterone and free androgen index test for those likely to have PCOS
  • Hysterosalpingography (HSG) or saline infusion USS (sonohysterography)

Other useful information for management (not an exhaustive list)

  • IVF not available in Mater public hospitals
  • Refer to HealthPathways and or local guidelines
  • Treatment is as a couple and requires a partner referral
  • To assess tubal patency, consider Hysterosalpingography (HSG) or saline infusion USS (sonohysterography) if history suggestive of blocked fallopian tubes
  • Seminal analysis of partner (≥4 days of abstinence). Repeat in 4-6 weeks if abnormal.
  • Lifestyle modification (increased activity, dietary, weight, smoking, alcohol)
    • simple moderate physical activity including structured exercise (at least 30 minutes/day) and optimising incidental exercise with weight loss and weight maintenance
    • achieve optimal weight BMI 20 – 30
    • referral to dietician
  • Infertility: folic Acid 0.5mg/day

Categorisation

Available appointments are provided to our patients based on clinical priority. A process of categorisation ensures safety and equity of access.

Category 1 – Urgent

Clinically recommended timeframe for initial appointment is 30 days

Category 2 - Priority

Clinically recommended timeframe for initial appointment is 90 days

Category 3 - Routine

Clinically recommended timeframe for initial appointment is 365 days

Reproductive counselling for fertility sparing options prior to cancer treatment including surgery and chemotherapy

All other category 1 referrals for interfility are not accepted, refer to a private specialist to avoid delay

Category 2 referral for infertility are not accepted, refer to a private specialist to avoid delay

All referrals for infertility for example but not limited to 

  • Surgical management of hydosalpinx
  • Anovulation for ovulation induction (selected cases)
  • Unexplained infertility (selected cases) 
  • Recurrent pregnancy loss

(Definition - Infertility is the failure to achieve pregnancy after 12 months or more of unprotected intercourse

 

Intermenstrual Bleeding

Essential information (Referral will be declined without this)

  • General referral information
  • History of abnormal bleeding / hormonal contraceptive use
  • Recent co-test result (HPV and LBC)
  • HVS result
  • BHCG result
  • STI screen result – endocervical swab or first catch urine for chlamydia +/- gonorrhoea NAA
  • Pelvic USS (TVS preferable)

Additional referral information (useful for processing the referral)

  • No additional information

Other useful information for management (not an exhaustive list)

Categorisation

Available appointments are provided to our patients based on clinical priority. A process of categorisation ensures safety and equity of access.

Category 1 – Urgent

Clinically recommended timeframe for initial appointment is 30 days

Category 2 - Priority

Clinically recommended timeframe for initial appointment is 90 days

Category 3 - Routine

Clinically recommended timeframe for initial appointment is 365 days

Oncogenic HPV, LBC prediction of pHSIL/HSIL, possible high-grade glandular lesion, AIS, or invasive cancer - cervical or endometrial

Focal endometrial lesion

IMB not due to hormonal contraception

Abnormal cervical screening )(other than for Cat 1) 

Endometrium  >12mm / irregular on pelvic USS (TVS ideally day 5-10)

Persistent and/or unexplained IMB

IMB bleeding related to hormonal contraception that is not responding to medical management e.g. contraception manipulation

 

 

Known or Suspected Endometriosis

Essential information (Referral will be declined without this)

  • General referral information
  • Medical management to date/surgical history
  • History of pain and menstrual diary
  • Symptoms
    • dysmenorrhoea
    • deep dyspareunia
    • dyschezia
  • history of sub-fertility
  • Pelvic USS results (TVS preferable) if available

Additional referral information (useful for processing the referral)

  • Menstrual diary (if available)

Other useful information for management (not an exhaustive list)

  • Refer to Healthpathways or local guidelines

Categorisation

Available appointments are provided to our patients based on clinical priority. A process of categorisation ensures safety and equity of access.

Category 1 – Urgent

Clinically recommended timeframe for initial appointment is 30 days

Category 2 - Priority

Clinically recommended timeframe for initial appointment is 90 days

Category 3 - Routine

Clinically recommended timeframe for initial appointment is 365 days

No category 1 criteria

Multiple emergency presentations

Endometriomas on USS

Endometriosis/chronic not responding to maximal medical management

Associated bowel or bladder disturbance

Endometriosis and reproductive issues

 

 

Mirena / Progesterone releasing IUD insertion or removal, for HMB or HRT

Essential information (Referral will be declined without this)

  • General referral information
  • Medical history - relevant family, menstrual, obstetric, contraceptive, and brief sexual history or history of STDS
  • Most recent or current cervical screening
  • Mirena® prescription – at Mater Hospital the referring GP does not need to provide a prescription for the device, nor is the patient required to bring the device with her to the clinic. The gynaecology clinic stocks and supplies Mirena devices according to usual PBS arrangements.

Additional referral information (useful for processing the referral)

  • Pelvic USS if lost strings, HMB or other clinical indication
  • STI screen result – endocervical swab or first catch urine for chlamydia +/- gonorrhoea NAA

Other useful information for management (not an exhaustive list)

  • Mirena® prescription to be supplied by referring GP. Patient must bring the device with her to the clinic
  • For paediatric and adolescent gynaecology patients please refer to statewide paediatric and adolescent gynaecology (SPAG) services at Queensland Children's Hospital/RBWH
  • Where available for the routine removal or insertion of Mirena®/progesterone releasing IUD please consider referral to True – relationships and reproductive health (formerly known as Family Planning Queensland) or a Women’s Health speciality primary care provider who may be able to provide this service in their own clinic.

Categorisation

Available appointments are provided to our patients based on clinical priority. A process of categorisation ensures safety and equity of access.

Category 1 – Urgent

Clinically recommended timeframe for initial appointment is 30 days

Category 2 - Priority

Clinically recommended timeframe for initial appointment is 90 days

Category 3 - Routine

Clinically recommended timeframe for initial appointment is 365 days

HMB with anaemia (Hb<85) or requiring transfusion

     HMB with anaemia (Hb>85)

HMB without anaemia not responding to maximal medical management

Contraception (if clinically indicated)

HRT

Replacement Mirena/Progesterone releasing IUD (if clinically indicated)

Mirena/Progesterone releasing IUD insertion or removal (if clinically indicated)

NB: Routine Mirena®/progesterone-releasing IUD insertion for contraception are out-of-scope for Gynaecology at Mater Health services.

 

Ovarian Cyst, Pelvic Mass

Essential information (Referral will be declined without this)

Additional referral information (useful for processing the referral)

  • Family history of breast and ovarian cancer
  • ROMA score in premenopausal women with elevated CA125
  • In paediatric and adolescent patients, remember to exclude germ cell tumours with markers: alpha feto protein LDH BHCG along with the other tumour markers

Other useful information for management (not an exhaustive list)

  • Refer to Healthpathways or local guidelines
  • ROMA score in premenopausal women with elevated CA125 would be beneficial to have at the time of the referral.  However, this may incur an out-of-pocket cost to the patient.
  • If cyst simple or haemorrhagic corpus luteal cyst and <5 cm repeat scan in 6 – 12 weeks
  • If recurrent cysts, consider COCP or Implanon®

Categorisation

Available appointments are provided to our patients based on clinical priority. A process of categorisation ensures safety and equity of access.

Category 1 – Urgent

Clinically recommended timeframe for initial appointment is 30 days

Category 2 - Priority

Clinically recommended timeframe for initial appointment is 90 days

Category 3 - Routine

Clinically recommended timeframe for initial appointment is 365 days

Suspicious of malignancy or high risk features:

  • USS findings such as solid areas, papillary projections, septations, abnormal blood flow, bilaterally or ascites
  • ovarian cyst >12cm
  • elevated CA125 and cyst >5cm in premenopausal patients or any size cyst in post-menopausal patient

Consider if significant pain and/or due to risk of torsion

Pre-pubertal patient

Persistent ovarian cyst >5cm on 2 pelvic USS 6 weeks apart

Complex cyst (haemorrhagic, endometriotic or dermoid)

Persistent pelvic pain

Hydrosalpinx

 

 

Pelvic Floor Dysfunction

Essential information (Referral will be declined without this)

  • General referral information
  • Obstetric and gynaecological history
  • History of:
    • prolapse symptoms
    • protruding lump
    • dragging sensation
    • difficulty with defecation (requiring manual evacuation) / micturition including incontinence
  • MSU M/C/S results

Additional referral information (useful for processing the referral)

  • Previous failed or complicated prolapse surgery
  • Pelvic USS (TVS preferable) if available
  • Bladder diary
  • Renal USS if major uterine procidenta

Other useful information for management (not an exhaustive list)

Categorisation

Available appointments are provided to our patients based on clinical priority. A process of categorisation ensures safety and equity of access.

Category 1 – Urgent

Clinically recommended timeframe for initial appointment is 30 days

Category 2 - Priority

Clinically recommended timeframe for initial appointment is 90 days

Category 3 - Routine

Clinically recommended timeframe for initial appointment is 365 days

Uterine procidentia

Difficulty voiding with renal impairment

Difficulty voiding +/- significant residuals on bladder screening (without renal impairment)

Recurrent UTIs

Genital fistulae

Mesh erosion or bleeding/pain

Any other prolapse or incontinence

Obstructive defecation

 

 

Pelvic Pain, Dysmenorrhoea, PMS

Essential information (Referral will be declined without this)

  • General referral information
  • History of/to:
    • pain, severity and duration, cyclical nature, dysmenorrhoea
    • differentiate from GI pain
    • previous sexual abuse, PID
    • medical management to date
  • Most recent or current cervical screening
  • HVS result
  • STI screen result – endocervical swab or first catch urine for chlamydia +/- gonorrhoea NAA
  • MSU M/C/S result
  • Pelvic USS (TVS preferable) if available

Additional referral information (useful for processing the referral)

  • No additional referral information

Other useful information for management (not an exhaustive list)

  • Refer to local Healthpathways or local guidelines

Medical management

  • Important to exclude cyclical bladder, bowel symptoms
  • Treat infection if present
  • Simple analgesia
  • Suppress menstrual cycle with oral contraceptive pill / implanon® / depo-provera / mirena®
  • Treat dysmenorrhoea with NSAIDS or COCP

Categorisation

Available appointments are provided to our patients based on clinical priority. A process of categorisation ensures safety and equity of access.

Category 1 – Urgent

Clinically recommended timeframe for initial appointment is 30 days

Category 2 - Priority

Clinically recommended timeframe for initial appointment is 90 days

Category 3 - Routine

Clinically recommended timeframe for initial appointment is 365 days

Suspicion of malignancy

Multiple emergency presentations

Pelvic pain and significant USS findings e.g. presence of endometriomas / fixed retroverted uterus

Chronic pain not responding to maximal medical management

 

Polycystic Ovarian Syndrome

Essential information (Referral will be declined without this)

  • General referral information
  • Pelvic ultrasound (incl. TVS)
  • Day 21 Progesterone (D21P)
  • SHBG results
  • Free Testosterone (FAI), DHEA-S results
  • Fasting blood glucose results
  • Lipids, TSH results

If problems with sub fertility:

  • History of
  • previous pregnancies, STDs and PID, surgery, endometriosis
  • other medical conditions
  • Include the following information about partner
  • age and health, reproductive history, testicular conditions
  • Weight/ BMI
  • FBC Group and antibodies Rubella IgG Varicella IgG, Syphilis Serology, HBV/HCV/HIV serology results
  • Day 21 serum progesterone level (7 days before the next expected period)
  • FSH, LH (Day 2-5), Prolactin, TSH if cycle prolonged and/or irregular
  • STI screen result – endocervical swab or first catch urine for chlamydia +/- gonorrhoea NAA
  • Partner semen analysis result
  • Pelvic USS (TVS preferable on day 5-10)

Additional referral information (useful for processing the referral)

  • No additional information

Other useful information for management (not an exhaustive list)

  • Psychological features need to be screened for, acknowledged, discussed and counselling considered, to improve quality of life in PCOS and to facilitate effective and sustainable lifestyle change  consideration of depression and/or anxiety and appropriate management
  • Emphasis on healthy lifestyle, with targeted medical therapy where indicated
  • Lifestyle modification (increased activity, dietary, weight, smoking, alcohol)
  • simple moderate physical activity including structured exercise (at least 30 minutes/day) and optimising incidental exercise assists with weight loss and weight maintenance
  • achieve optimal weight BMI 20 – 30
  • referral to dietician

Categorisation

Available appointments are provided to our patients based on clinical priority. A process of categorisation ensures safety and equity of access.

Category 1 – urgent

Clinically recommended timeframe for initial appointment is 30 days

Category 2 - Priority

Clinically recommended timeframe for initial appointment is 90 days

Category 3 - Routine

Clinically recommended timeframe for initial appointment is 365 days

 

Abnormal endometrium on ultrasound (i.e. irregular / focal lesion or thickened – over 12mm)

No category 2 criteria

Polycystic ovarian syndrome as per Rotterdam criteria

Diagnostic criteria for Rotterdam diagnosis of polycystic ovary syndrome
Two of the following three criteria are required:

  • polycystic ovaries on ultrasound (either 25 or more follicles per ovary or increased ovarian size (>10 cc)
  • oligo/anovulation
  • hyperandrogenism
    • clinical (hirsutism or less commonly male pattern alopecia) or
    • biochemical (raised FAI or free testosterone)

 

Post-Coital Bleeding

Essential information (Referral will be declined without this)

  • General referral information
  • Findings of speculum examination
  • Recent co-test result (HPV and LBC)
  • HVS result
  • Sexual health history
  • STI screen result - endocervical swab or first catch urine for chlamydia +/- gonorrhoea NAA

Additional referral information (useful for processing the referral)

  • Pelvic USS (TVS preferable)
  • Contraceptive use

Other useful information for management (not an exhaustive list)

  • Refer to local Healthpathways or local guidelines
  • Pre-menopausal women who have a single episode of post-coital bleeding and a clinically normal cervix do not need to be reported if oncogenic HPV is not detected and LBC is negative

Categorisation

Available appointments are provided to our patients based on clinical priority. A process of categorisation ensures safety and equity of access.

Category 1 – Urgent

Clinically recommended timeframe for initial appointment is 30 days

Category 2 - Priority

Clinically recommended timeframe for initial appointment is 90 days

Category 3 - Routine

Clinically recommended timeframe for initial appointment is 365 days

Suspected malignancy

SCC, positive oncogenic HPV and/or HSIL on LBC, glandular lesion on cervical screening

Post-coital bleeding recurs or persists despite negative HPV or LBC

No category 3 criteria

 

 

Post-Menopausal Bleeding

Essential information (Referral will be declined without this)

Additional referral information (useful for processing the referral)

  • BMI

Other useful information for management (not an exhaustive list)

  • Refer to local Healthpathways or local guidelines
  • Postmenopausal women with an incidental finding on pelvic ultrasound of a regular endometrial thickness of less than 11mm and having no episodes of postmenopausal bleeding would only need a repeat ultrasound and referral if developing vaginal bleeding

Categorisation

Available appointments are provided to our patients based on clinical priority. A process of categorisation ensures safety and equity of access.

Category 1 – Urgent

Clinically recommended timeframe for initial appointment is 30 days

Category 2 - Priority

Clinically recommended timeframe for initial appointment is 90 days

Category 3 - Routine

Clinically recommended timeframe for initial appointment is 365 days

Endometrial thickness >4mm

Cervical polyps

Suspicion of malignancy

Focal endometrial lesion

Endometrial thickness ≤4mm

No category 3 criteria

 

 

Primary, Secondary Amenorrhoea

Essential information (Referral will be declined without this)

Additional referral information (useful for processing the referral)

  • Renal USS 

Other useful information for management (not an exhaustive list)

  • Primary amenorrhoea – is defined as the absence of menses at age 16 years in the presence of normal growth and secondary sexual characteristics and 14 in the absence of secondary sexual characteristics
  • Secondary amenorrhoea – absence of menses for more than six months after the onset of menses
  • Refer to statewide paediatric and adolescent gynaecology (SPAG) services at Queensland Children's Hospital/RBWH
  • Address excessive exercise or dieting
  • If BMI is greater than 30, manage weight loss
  • Address any significant stress or anxiety
  • Review medications if relevant (e.g. antipsychotics, metoclopramide)
  • Cyclical abdominal pain in adolescent with primary amenorrhoea might be indication of imperforate hymen

Categorisation

Available appointments are provided to our patients based on clinical priority. A process of categorisation ensures safety and equity of access.

Category 1 – Urgent

Clinically recommended timeframe for initial appointment is 30 days

Category 2 - Priority

Clinically recommended timeframe for initial appointment is 90 days

Category 3 - Routine

Clinically recommended timeframe for initial appointment is 365 days

No category 1 criteria

Primary amenorrhoea

Secondary amenorrhoea

 

Vulva lesion, Genital warts, Boil, Swelling, Abscess, Ulcer, Bartholin's Cyst

Essential information (Referral will be declined without this)

  • General referral information
  • History of:
    • Pain, swelling
    • pruritus
    • dyspareunia
    • localised lesions (pigmented or non-pigmented lesions)
    • STIs or other vaginal infections
    • local trauma
  • Elicit onset, duration and course of presenting symptoms
  • Date of last menstrual period
  • Medical management to date
  • Cervical screening if referral for warts

Additional referral information (useful for processing the referral)

  • Vulva ulcers – swab M/C/S and viral PCR result
  • Vulval rashes – scraping, swaps or biopsy (as appropriate)
  • STI screen result -endocervical swab or first catch urine for chlamydia +/- gonorrhoea NAA (as appropriate)
  • Syphillis HIV serology (as appropriate)

Other useful information for management (not an exhaustive list)

  • For or paediatric and adolescent gynaecology patients, please refer to statewide paediatric and adolescent gynaecology (SPAG) services at Queensland Children's Hospital/RBWH
    • <14 years refer to Queensland Children's Hospital
    • >14 years refer to RBWH or local adolescent gyane service
  • Antibiotic treatment of Bartholins cyst is of no value.
  • In women where a vulval cancer is strongly suspected on examination, urgent referral should not await biopsy
  • Vulval cancers may present as unexplained lumps, bleeding from ulceration or pain.
  • Vulval cancer may also present with pruritus or pain. For a patient who presents with these symptoms and where cancer is not immediately suspected, it is reasonable to use a period of ‘treat, watch and wait’ as a method of management. However, this should include active follow-up until symptoms resolve or a diagnosis is confirmed. If symptoms persist, the referral may be urgent or non-urgent, depending on the symptoms and the degree of concern about cancer.

Categorisation

Available appointments are provided to our patients based on clinical priority. A process of categorisation ensures safety and equity of access.

Category 1 – Urgent

Clinically recommended timeframe for initial appointment is 30 days

Category 2 - Priority

Clinically recommended timeframe for initial appointment is 90 days

Category 3 - Routine

Clinically recommended timeframe for initial appointment is 365 days

Vulval disease with suspicion of malignancy. For optimum care, patient should be seen within 2 weeks.   

Unexplained vulval lump, ulceration or bleeding. For optimum care, patient should be seen within 2 weeks.   

Postmenopausal women with abnormal vulval lesions

Pregnant or immunosuppressed

Suspected vulval dystrophy

Bartholin’s cysts or other vulval  cysts in patients >40 years old

Vulval warts where:

  • the patient is immunocompromised (e.g. HIV positive, immunosuppressant medications)
  • the diagnosis is unclear
  • atypical genital warts (including pigmented lesions)
  • atypical genital warts (including pigmented lesions)
  • there are positive results from the screen for other STI’s

Vulval lesion where:

  • there is treatment failure or where treatment cannot be tolerated due to side-effects
  • there are problematic recurrences

Vulval rashes

Vulval warts

Bartholin’s cyst/labial cysts

 

Other Gynaecology Condition

Essential information (Referral will be declined without this)

Categorisation

Available appointments are provided to our patients based on clinical priority. A process of categorisation ensures safety and equity of access.

Category 1 – urgent

Clinically recommended timeframe for initial appointment is 30 days

Category 2 - Priority

Clinically recommended timeframe for initial appointment is 90 days

Category 3 - Routine

Clinically recommended timeframe for initial appointment is 365 days

 

 

Our Specialists

 

Dr Michael Beckmann Director of Obstetrics and Gynaecology
Dr Bob Baade

Gynaecologist

Dr David Hodgson

Gynaecologist

Dr Tal Jacobson

Gynaecologist

Dr Luke McLindon

Gynaecologist

Dr Kym Warhurst

Gynaecologist

Dr Peta Wright Gynaecologist/Adolescent Gynaecology
Dr Amy Mellor Gyanecologist/Adolescent Gyanecology

Contact Us

If you would like to discuss a referral, including clinical criteria, or update the status of a current patient please contact our priority GP phone line on 07 3163 2200

Current Waiting Time for Appointments

We provide up to date data on how long patients are waiting for their first appointment by specialtly here.

Referral Guideline Development

These Mater Referral Guidelines align with standardised best practice tools for referral to publicly funded specialist outpatient services developed in Queensland through the Clinical Prioritisation Criteria project.

 

Content last reviewed: 1 June 2018

 

 
  • Mater at Home

    Providing local communities with access to integrated health care & services.

    Read more

  • Professional Development

    GP Education, Maternity Shared Care Alignment Program and Events.

    Read more

  • Featured Event

    Virtual education session: Prostate update: PSA and Benign Prostatic Hyperplasia 12 August 2020

    Read more